Back to Search
ASLIHAN YERLIKAYA, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1144898206Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (5)
Differential sensitivity of breast cancer and melanoma cells to proteasome inhibitor Velcade.
PMID 19020781·Int J Mol Med·2008
8-other
Phosphorylation of eIF2alpha in response to 26S proteasome inhibition is mediated by the haem-regulated inhibitor (HRI) kinase.
PMID 18290760·Biochem J·2008
7-preclinical
Structural basis for the inactivation of AdoMetDC K12R mutant.
PMID 16515461·Protein Pept Lett·2006
7-preclinical
Influence of dietary oils on liver and blood lipid peroxidation.
PMID 15806216·Saudi Med J·2005
7-preclinical
S-adenosylmethionine decarboxylase degradation by the 26 S proteasome is accelerated by substrate-mediated transamination.
PMID 14718534·J Biol Chem·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 111 E 210TH ST
BRONX, NY 10467 - Phone
- (718) 920-2926
Quick Facts
- NPI
- 1144898206
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 5
Are you this provider?
Claim Your Profile